AI App to Detect Diabetic Retinopathy: India has unveiled Madhunetrai, an AI-powered screening app designed to detect diabetic retinopathy (DR) at an early stage. Developed by AIIMS, this marks a major breakthrough in India’s healthcare technology ecosystem. According to the Economic Times, Madhunetrai is India’s first fully validated AI tool for retinal disease detection – a significant achievement for medical AI innovation.
The launch contributes to growing momentum around Latest AI news India and strengthens India’s position in AI innovation in India.
Why Diabetic Retinopathy Detection Matters
Key Features of the Madhunetrai App
-
AI-powered retinal image analysis
-
Instant risk detection for diabetic retinopathy
-
Can be used by non-specialist healthcare workers
-
Supports remote and rural screening
-
Fully validated through clinical studies
Trusted Facts
-
WHO estimates that diabetic retinopathy is responsible for 4.8% of global blindness cases, making early detection critical.
-
India has over 77 million diabetic patients, one of the highest globally – increasing the risk of DR significantly.
With such large patient numbers, Madhunetrai can help accelerate screening and reduce preventable vision loss.
A Step Forward in India’s Healthcare AI
Madhunetrai represents a major milestone in bringing Artificial Intelligence insights to the healthcare sector.
The app simplifies early DR detection, enabling faster diagnosis, easier follow-ups, and better patient outcomes – especially in underserved communities.
If you know doctors, healthcare workers, or AI professionals, share this news so more people are aware of how AI is saving sight across India.
Follow our WhatsApp Channel for more AI updates: https://whatsapp.com/channel/0029Vb5ceY57T8bVamXJma1T
